Gilles A, Antoine M, Vincent J L, Leeman M
Service de Chirurgie Cardiaque, Hôpital Erasme, U.L.B.
Rev Med Brux. 2001 Oct;22(5):436-8.
Peripartum cardiomyopathy is a rare, potentially life-threatening cardiomyopathy of unknown cause. Diagnosis includes clinical (development of cardiac failure in the last month of pregnancy or within 5 months after delivery, absence of an identifiable cause of cardiac failure and absence of recognizable heart disease prior to the last month of pregnancy) and echographic (left ventricular systolic dysfunction) criteria. Therapy is standard, except for angiotensin converting enzyme inhibitors, which should be avoided at the end of pregnancy, and heart transplantation if medical treatment fails. We report the case of a 24 year-old woman who required left ventricular assistance as a bridge before cardiac transplantation.
围产期心肌病是一种罕见的、潜在危及生命的病因不明的心肌病。诊断包括临床标准(在妊娠最后1个月或产后5个月内出现心力衰竭,无明确的心力衰竭病因且在妊娠最后1个月前无明显心脏病史)和超声心动图标准(左心室收缩功能障碍)。治疗是标准的,但妊娠末期应避免使用血管紧张素转换酶抑制剂,若药物治疗无效则考虑心脏移植。我们报告了一例24岁女性的病例,该患者在心脏移植前需要左心室辅助作为过渡。